TD Cowen analyst Andrew Kligerman lowered the firm’s price target on Berkshire Hathaway (BRK.B) to $479 from $485 and keeps a Hold rating on the shares. The firm revised its 2025/2026 estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRK.B:
- UnitedHealth price target raised to $325 from $290 at BofA
- Semper Augustus Boosts Stake in Berkshire Hathaway B
- Bill & Melinda Gates Foundation Trust Boosts Berkshire Hathaway B Stake
- Chilton Investment Co LLC Reduces Stake in Berkshire Hathaway B
- Graham Capital Management Boosts Stake in Berkshire Hathaway